Abemaciclib Delivers New Overall Survival Data in Early Breast Cancer Patients Medical Dialogues Team7 Jan 2026 10:45 AM ISTIn this short video, Prof Stephen Johnston, Consultant Medical Oncologist, Royal Marsden Hospital and Institute of Cancer Research, London, ...
Latest Triple Combination of Empagliflozin, Sitagliptin and Metformin for Advanced Care in Indian T2DM Patients - When to Consider? Dr. Nandita Mohan3 Jan 2026 11:15 AM ISTIn this episode of The Diabetes Wellness Forum, titled "Importance of Early Aggressive Glucose Control-Approach in 2025," Dr Nandita Mohan from...
New Book on Early Breast Cancer Released at ISMPO Congress: A Comprehensive, Evidence-Based Guide for Clinicians Medical Dialogues Team2 Jan 2026 10:30 AM ISTThe Indian Society of Medical and Pediatric Oncology (ISMPO) Congress which was recently held in Jaipur saw the launch of a major new resource,...
Early-Onset Hypertension and Elevated ASCVD Risk: When Does Aspirin Fit? Dr. Laxman Gaikwad1 Jan 2026 11:30 AM ISTThe epidemiology of hypertension in India has undergone a malignant shift, moving from a disease of the elderly to a pervasive condition in the...
Humanized Medicine in 2026 Dr. Bhumika Maikhuri1 Jan 2026 11:15 AM ISTAs health systems worldwide enter a new year marked by rapid technological expansion, rising costs, and ageing populations, a fundamental question...
2 Years of Treatment, 7 Years of Benefits: Abemaciclib Delivers New Overall Survival Data in Breast Cancer Patients Dr. Bhumika Maikhuri26 Dec 2025 11:45 AM ISTIn this short video, Dr Nitesh Rohtagi, Principal Director, Department of Medical Oncology, Fortis Cancer Institute, Delhi and Gurugram, discusses...
This isn't the Durability You Thought You Knew: A Fresh Perspective on Psoriasis Dr. Bhumika Maikhuri24 Dec 2025 10:30 AM ISTIn this short video, Matteo Megna, Associate Professor at the University of Naples Federico II, Naples, Italy, discusses durability as a novel ...
ESMO 2025 Update: Effect of Abemaciclib added to standard Endocrine Therapy in High-Risk Early Breast Cancer Medical Dialogues Team23 Dec 2025 11:30 AM ISTAdjuvant abemaciclib combined with endocrine therapy (ET) has demonstrated a statistically significant and clinically meaningful improvement in...
Cardio-Metabolic Risk and Aspirin: What Does the Evidence Say for Indian Patients? Dr. Deepak Gupta19 Dec 2025 11:30 AM ISTIndia carries a heavy cardiometabolic burden of nearly 30%, intensified by early-onset diabetes, hypertension, dyslipidaemia, and obesity patterns...
Targeting IL-17A may Modify Risk Factors for Psoriatic Arthritis in Patients with Psoriasis Dr. Bhumika Maikhuri19 Dec 2025 11:00 AM ISTOverviewIn this short video, Dr. Paolo Gisondi, MD, Associate Professor of Dermatology and Venereology at the University of Verona, Italy, discusses...
Reperfusion Therapy for STEMI in LMICs: A Clinical Consensus Discussion with Dr Thomas Alexander Deeksha Bhandari12 Dec 2025 12:15 PM ISTIn this video, renowned cardiologist Dr Thomas Alexander, Senior Interventional Cardiologist and Head of the Division of Cardiology at Kovai Medical...
Real-World Outcomes of Dydrogesterone ER 20 mg in Recurrent Pregnancy Loss Deeksha Bhandari11 Dec 2025 12:20 PM ISTRecurrent Pregnancy Loss (RPL) Burden in India Recurrent pregnancy loss (RPL) is defined as two or more consecutive pregnancy losses before 20...
